farnesol has been researched along with itraconazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brilhante, RS; Castelo-Branco, DS; Cordeiro, RA; Giffoni Leite, JJ; Lima, DT; Monteiro, AJ; Paiva, MA; Rocha, MF; Sidrim, JJ; Teixeira, CE | 1 |
| Bandeira, TJPG; Brilhante, RSN; Caetano, ÉP; Camargo, ZP; Castelo-Branco, DSCM; Cordeiro, RA; de Lima, RAC; Marques, FJF; Monteiro, AJ; Moreira, JLB; Rocha, MFG; Sidrim, JJC; Silva, NF | 1 |
| Černáková, L; Dos Santos, ALS; Falahatinejad, M; Mohammadi, SR; Nikoomanesh, F; Rafiee, M; Rodrigues, CF; Roudbary, M | 1 |
3 other study(ies) available for farnesol and itraconazole
| Article | Year |
|---|---|
Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Farnesol; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests | 2013 |
Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Drug Synergism; Farnesol; Histoplasma; Itraconazole; Microbial Sensitivity Tests; Microbial Viability | 2015 |
Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against
Topics: Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis, Vulvovaginal; Farnesol; Female; Fluconazole; Humans; Itraconazole | 2023 |